Drugs and Medical Devices: Adverse Events and the Impact on Women’s Health

详细信息    查看全文

• 作者：Jennifer L. Carey ; MD¹ ; ^{jennifer.carey@umassmemorial.org} ; Nathalie Nader ; BA¹ ; Peter R. Chai ; MD ; MMS¹ ; Stephanie Carreiro ; MD¹ ; Matthew K. Griswold ; MD¹ ; Katherine L. Boyle ; MD²
• 关键词：sex and gender ; medication and device safety
• 刊名：Clinical Therapeutics
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：39
• 期：1
• 页码：10-22
• 全文大小：350 K
• 卷排序：39

文摘

A large number of medications and medical devices removed from the market by the US Food and Drug Administration over the past 4 decades specifically posed greater health risks to women. This article reviews the historical background of sex and gender in clinical research policy and describes several approved drugs and devices targeted for use in women that have caused major morbidity and mortality. The intended population for the medications and devices, population affected, approval process, and the basic and legal actions taken against the medication/drug company are also discussed. It is recognized that women are still at risk for harm from unsafe medications and devices, and continued improvements in legislation that promotes inclusion of sex and gender into the design and analysis of research will improve safety for both men and women.